Streptococcus and STI Unit
The Streptococcus and STI Unit provides surveillance, reference diagnostic services, and research on Streptococcus pneumoniae and Streptococcus pyogenes. Data generated is used for streptococcal vaccine development and evaluation. In addition, this laboratory supports provincial public health laboratories in the characterization of streptococcal isolates for outbreak support. The Unit participates in international and national surveillance programs such as the Canadian Nosocomial Infection Surveillance Program (CAN-WARD), the Immunization Monitoring Program Active (IPMACT) and International Circumpolar Surveillance (ICS). The Streptococcus and STI Unit also provides surveillance, reference diagnostic services, and research on Neisseria gonorrhoeae, Mycoplasma spp and Ureaplasma spp. The N. gonorrhoeae work focuses on monitoring trends in antimicrobial susceptibilities in order to assist in Canadian STI treatment guidelines. Research activities include the molecular characterization of isolates. In recent years, there has been an increase in the number of STIs reported in Canada as well as the emergence of gonococcal strains with decreased susceptibility to 3rd generation cephalosporins and resistance to azithromycin.